Comparison of FENO reduction in asthmatic children treated with inhaled budesonide-MDI with two-valved, non valved, or home-made spacers

J. M. Figueroa, C. Velasco Suarez, M. Roque, V. Badaracco, A. M. Balanzat (Buenos Aires, Argentina)

Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Session: Anti-inflammatory therapy for childhood asthma
Session type: Electronic Poster Discussion
Number: 2714
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. M. Figueroa, C. Velasco Suarez, M. Roque, V. Badaracco, A. M. Balanzat (Buenos Aires, Argentina). Comparison of FENO reduction in asthmatic children treated with inhaled budesonide-MDI with two-valved, non valved, or home-made spacers. Eur Respir J 2007; 30: Suppl. 51, 2714

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of bronchodilator effect of salbutamol delivered via MDI + spacer and DPI in children with asthma
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012


Are non-valved spacers useful for long-term treatment with inhaled steroids in asthmatic young children?
Source: Eur Respir J 2005; 26: Suppl. 49, 160s
Year: 2005

Bronchodilatation and systemic β2-response measurement in asthmatic patients after using salbutamol comparing a metal and a plastic spacer
Source: Eur Respir J 2001; 18: Suppl. 33, 99s
Year: 2001

Metered dose inhaler with spacer versus nebulizer in children with acute bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 429s
Year: 2002

Bioavailability of inhaled fluticasone propionate via chambers/masks in young children
Source: Eur Respir J 2011; 39: 97-103
Year: 2012



Bioavailability of inhaled fluticasone propionate via chambers/masks in young children
Source: Eur Respir J 2012; 39: 97-103
Year: 2012



Influence of pulmonary function on spacer use for HFA-salbutamol inhalation in asthmatic patients
Source: Eur Respir J 2005; 26: Suppl. 49, 126s
Year: 2005

Effect of inhaled steroids on lung function in young children: a cohort study
Source: Eur Respir J 2004; 23: 869-875
Year: 2004



Improved asthma control with budesonide/formoterol via a single inhaler, compared with budesonide alone, in moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 48s
Year: 2001

Comparison of HFA salmeterol-fluticasone (SFC) combination when given through breath actuated inhaler (BAI) and pressurised meter dose inhaler (pMDI) in patients with moderate-to-severe asthma
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013


Efficacy of combined budesonide/formoterol delivered via turbuhaler on lung function and asthma control in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 496s
Year: 2003

The effects of different inhaler devices on asthma control in patients with persistent asthma in Turkey
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012


Broncho dilator response to salbutamol delivered by metered dose inhaler with spacer versus dry powder inhaler in acute asthma in children
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016

Comparison of inhaler device preference of the physicians in the treatment of newly diagnosed adult asthma and COPD patients
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019


Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol
Source: Eur Respir J 2004; 24: Suppl. 48, 581s
Year: 2004

Effect of montelukast added to inhaled steroids on exhaled NO in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 40s
Year: 2001

Inhalation characteristics of asthmatic children (child), adults asthmatics (adult) and chronic obstructive pulmonary disease patients when they inhale through a spiromax dry powder inhaler (DPI)
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Comparison of pulmonary and systemic absoption of two HFA formulations of salmeterol in healthy subjects
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010

Comparison of HFA fluticasone-formoterol combination pressurized meter dose inhaler (pMDI) and HFA budesonide-formoterol combination pMDI in patients with moderate to severe persistent asthma
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010


Preference of the inhaler device and assessment of the technique among the asthmatic and COPD patients
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011